Ankle Injuries Among the Most Common Sports Injuries as Baseball Season Kicks Off
ATLANTA, GEORGIA / ACCESS Newswire / February 18, 2026 / Ankle & Foot Centers of America is encouraging patients not...
Day: February 18, 2026
Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10
Initial presentation on January 26, 2026 showcased Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing...
Relief AI Inc. Congratulates Johannes “Hansi” Lochner on Historic Gold Medal Victory at the Milano, Cortina Italy Olympics
Toronto, Ontario--(Newsfile Corp. - February 18, 2026) - Relief AI Inc. (the "Company "or "Relief AI Inc.") (www.reliefai.ca), Relief AI...
15,000 Professionals Take Part in Association for the Advancement of Medical Instrumentation
Arlington, Virginia--(Newsfile Corp. - February 18, 2026) - More than 15,000 health technology professionals and organizations are now leveraging the...
Jaguar Health Announces a Special One-time Stock Dividend
Dividend intended to provide dilution protection to Jaguar shareholders as company explores pathway to restructure debt SAN FRANCISCO, CA /...
FDA Grants PMA Approval to LimiFlex(TM) Dynamic Sagittal Tether
Motion-Preserving Lumbar Spine Surgery - Stabilization Without Fusion for Patients with Degenerative Spondylolisthesis SAN CARLOS, CALIFORNIA / ACCESS Newswire /...
Tenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion
Expanded Global Portfolio Enhances Competitive Position and Supports Long-Term Growth Strategy LOS GATOS, CA / ACCESS Newswire / February 18,...
Wellgistics Health Targets Expansion into $6.3 Billion Mental Health Software Market with Strategic Investment into Stealth Mental Health AI Startup
Previously announced partnership with Tollo Health subsidiary TolloCare adding telehealth service offering to drive Wellgistics Pharmacy prescription drug dispending of...
AQP ONE Launches JBA AICare(TM), Introducing a Physiological Intelligence System into the $100+ Billion Global Wearable Market
GARDEN GROVE, CA / ACCESS Newswire / February 18, 2026 / AQP ONE Inc., a U.S.-based health technology company founded...
Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
Following a Type A meeting, the FDA's Center for Biologics Evaluation and Research has notified Moderna that its biologics license...
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
MELBOURNE, Australia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company...
24/7 Market News- It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough
One Million Transgenic Silkworms Being Deployed as Production Targets 10 Metric Tons per MonthDENVER, Feb. 18, 2026 (GLOBE NEWSWIRE) --...
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
Conference Call Scheduled for Thursday, March 5, 2026 at 9:00 AM ETPORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell...
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
David E. I. Pyott David E. I. Pyott, former Chairman and CEO of Allergan, Inc., was appointed to Tarsus Pharmaceuticals'...
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
GLP-1 Usage Increases 67% While Bariatric Surgeries Decline, but Long-Term Benefits Remain Unclear
GREENWICH, Conn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- A new analysis by Cedar Gate Technologies, an IQVIA business (Cedar Gate),...
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
Patent strengthens protection for novel PTSD drug and advances the Company’s international IP strategySARASOTA, FL, Feb. 18, 2026 (GLOBE NEWSWIRE)...
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
Preliminary blinded CR rate showed 67% improvement over historical cytarabine response Roughly 35% of the subjects treated to date represent...
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare MarketSimple, FDA-Cleared At-Home Test Detects an Early Warning Sign...
Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need
Stenoparib is being evaluated in combination with temozolomide clinical benefit in relapsed Small Cell Lung CancerTrial is fully...